CLINICAL TRIALS PROFILE FOR CHOLERA VACCINE, LIVE, ORAL

All Clinical Trials for cholera vaccine, live, oral

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00654108 ↗	Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult Subjects	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1	2008-06-02	Enterotoxigenic Escherichia (E.) coli (ETEC) bacteria are the main cause of traveler's diarrhea and are significant pathogens affecting children and elderly individuals of developing countries. The purpose of the study is to determine the safety of the ETEC-Cholera vaccine and the body's ability to protect itself against ETEC and cholera infection after receiving the vaccine. The study will enroll a total of 64 healthy volunteers, 18 to 45 years old at the Cincinnati Children's Hospital. The study will provide increasing doses of the vaccine or placebo (inactive substance) to 4 groups consisting of 16 participants each. Participants will remain in the inpatient unit for observation for about 11 days. All subjects will be treated with Cipro, an antibiotic, for 5 days. Study procedures include: blood samples, vital signs, physical examinations, and stool samples. Volunteers will be involved in the study for about 8 months including telephone contacts.
NCT00969878 ↗	Multisite Controlled Trial of Cocaine Vaccine	Completed	Celtic Pharma Development Services	Phase 2	2010-08-01	The purpose of this study is to test the efficacy of a newly developed active vaccine against cocaine (TA-CD).
NCT00969878 ↗	Multisite Controlled Trial of Cocaine Vaccine	Completed	Columbia University	Phase 2	2010-08-01	The purpose of this study is to test the efficacy of a newly developed active vaccine against cocaine (TA-CD).
NCT00969878 ↗	Multisite Controlled Trial of Cocaine Vaccine	Completed	Johns Hopkins University	Phase 2	2010-08-01	The purpose of this study is to test the efficacy of a newly developed active vaccine against cocaine (TA-CD).

Clinical Trial Conditions for cholera vaccine, live, oral

Condition Name

Condition Name for cholera vaccine, live, oral
Intervention	Trials
Cholera	2
Fever	1
Gastroenteritis Escherichia Coli	1
Inflammatory Bowel Disease	1

Condition MeSH

Condition MeSH for cholera vaccine, live, oral
Intervention	Trials
Cholera	4
Typhoid Fever	2
Cocaine-Related Disorders	1
Gastroenteritis	1

Clinical Trial Locations for cholera vaccine, live, oral

Trials by Country

Trials by Country for cholera vaccine, live, oral
Location	Trials
United States	9
Bangladesh	2
Vietnam	1
United Kingdom	1

Trials by US State

Trials by US State for cholera vaccine, live, oral
Location	Trials
Maryland	3
Ohio	2
Georgia	1
Texas	1
Pennsylvania	1

Clinical Trial Progress for cholera vaccine, live, oral

Clinical Trial Phase

Clinical Trial Phase for cholera vaccine, live, oral
Clinical Trial Phase	Trials
Phase 4	2
Phase 2	3
Phase 1/Phase 2	1

Clinical Trial Status

Clinical Trial Status for cholera vaccine, live, oral
Clinical Trial Phase	Trials
Completed	6
Recruiting	2
Suspended	1

Clinical Trial Sponsors for cholera vaccine, live, oral

Sponsor Name

Sponsor Name for cholera vaccine, live, oral
Sponsor	Trials
University of Maryland	2
University of Maryland, Baltimore	2
International Centre for Diarrhoeal Disease Research, Bangladesh	2

Sponsor Type

Sponsor Type for cholera vaccine, live, oral
Sponsor	Trials
Other	16
U.S. Fed	2
NIH	2